0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceuticals and Excipients Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19P6960
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceuticals Excipients Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pharmaceuticals and Excipients Market Research Report 2025

Code: QYRE-Auto-19P6960
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceuticals and Excipients Market Size

The global market for Pharmaceuticals and Excipients was valued at US$ 100980 million in the year 2024 and is projected to reach a revised size of US$ 137730 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Pharmaceuticals and Excipients Market

Pharmaceuticals and Excipients Market

Pharmaceutical Excipients are any materials that are added to the drug formulation other than API (Active Pharmaceutical Ingredient) in order to fill up the dosage form (fillers) OR to aid in formulation (Binders, disintegrants, glidents, lubricants) OR to aid in stabilizing the drug product (Preservatives) OR to aid palatability (Sweeteners, flavors, colorants) OR to aid modified release (Polymers, coating materials) etc.,
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceuticals and Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceuticals and Excipients.
The Pharmaceuticals and Excipients market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceuticals and Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceuticals and Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharmaceuticals and Excipients Market Report

Report Metric Details
Report Name Pharmaceuticals and Excipients Market
Accounted market size in year US$ 100980 million
Forecasted market size in 2031 US$ 137730 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dow, BASF, ER-KANG, JRS Pharma, Lubrizol, Ashland, Roquette, Shin-Etsu, Evonik, ABITEC Corp, Signet Chemical Corporation, Sigachi Industries, MEGGLE AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceuticals and Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceuticals and Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pharmaceuticals and Excipients Market growing?

Ans: The Pharmaceuticals and Excipients Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Pharmaceuticals and Excipients Market size in 2031?

Ans: The Pharmaceuticals and Excipients Market size in 2031 will be US$ 137730 million.

Who are the main players in the Pharmaceuticals and Excipients Market report?

Ans: The main players in the Pharmaceuticals and Excipients Market are Dow, BASF, ER-KANG, JRS Pharma, Lubrizol, Ashland, Roquette, Shin-Etsu, Evonik, ABITEC Corp, Signet Chemical Corporation, Sigachi Industries, MEGGLE AG

What are the Application segmentation covered in the Pharmaceuticals and Excipients Market report?

Ans: The Applications covered in the Pharmaceuticals and Excipients Market report are Oral Formulations, Topical Formulations, Parenteral Formulations, Other

What are the Type segmentation covered in the Pharmaceuticals and Excipients Market report?

Ans: The Types covered in the Pharmaceuticals and Excipients Market report are Triglycerides, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Others

Recommended Reports

Pharma Packaging Solutions

Pharma Excipients Market

Pharma Supply & Services

1 Pharmaceuticals and Excipients Market Overview
1.1 Product Definition
1.2 Pharmaceuticals and Excipients by Type
1.2.1 Global Pharmaceuticals and Excipients Market Value Comparison by Type (2024 VS 2031)
1.2.2 Triglycerides
1.2.3 Mannitol
1.2.4 Sorbitol
1.2.5 Sucrose
1.2.6 Dextrose
1.2.7 Starch
1.2.8 Others
1.3 Pharmaceuticals and Excipients by Application
1.3.1 Global Pharmaceuticals and Excipients Market Value by Application (2024 VS 2031)
1.3.2 Oral Formulations
1.3.3 Topical Formulations
1.3.4 Parenteral Formulations
1.3.5 Other
1.4 Global Pharmaceuticals and Excipients Market Size Estimates and Forecasts
1.4.1 Global Pharmaceuticals and Excipients Revenue 2020-2031
1.4.2 Global Pharmaceuticals and Excipients Sales 2020-2031
1.4.3 Global Pharmaceuticals and Excipients Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceuticals and Excipients Market Competition by Manufacturers
2.1 Global Pharmaceuticals and Excipients Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceuticals and Excipients Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceuticals and Excipients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceuticals and Excipients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceuticals and Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceuticals and Excipients, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceuticals and Excipients, Date of Enter into This Industry
2.8 Global Pharmaceuticals and Excipients Market Competitive Situation and Trends
2.8.1 Global Pharmaceuticals and Excipients Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceuticals and Excipients Players Market Share by Revenue
2.8.3 Global Pharmaceuticals and Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceuticals and Excipients Market Scenario by Region
3.1 Global Pharmaceuticals and Excipients Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceuticals and Excipients Sales by Region: 2020-2031
3.2.1 Global Pharmaceuticals and Excipients Sales by Region: 2020-2025
3.2.2 Global Pharmaceuticals and Excipients Sales by Region: 2026-2031
3.3 Global Pharmaceuticals and Excipients Revenue by Region: 2020-2031
3.3.1 Global Pharmaceuticals and Excipients Revenue by Region: 2020-2025
3.3.2 Global Pharmaceuticals and Excipients Revenue by Region: 2026-2031
3.4 North America Pharmaceuticals and Excipients Market Facts & Figures by Country
3.4.1 North America Pharmaceuticals and Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceuticals and Excipients Sales by Country (2020-2031)
3.4.3 North America Pharmaceuticals and Excipients Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharmaceuticals and Excipients Market Facts & Figures by Country
3.5.1 Europe Pharmaceuticals and Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceuticals and Excipients Sales by Country (2020-2031)
3.5.3 Europe Pharmaceuticals and Excipients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceuticals and Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceuticals and Excipients Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceuticals and Excipients Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceuticals and Excipients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pharmaceuticals and Excipients Market Facts & Figures by Country
3.7.1 Latin America Pharmaceuticals and Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceuticals and Excipients Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceuticals and Excipients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceuticals and Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceuticals and Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceuticals and Excipients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceuticals and Excipients Sales by Type (2020-2031)
4.1.1 Global Pharmaceuticals and Excipients Sales by Type (2020-2025)
4.1.2 Global Pharmaceuticals and Excipients Sales by Type (2026-2031)
4.1.3 Global Pharmaceuticals and Excipients Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceuticals and Excipients Revenue by Type (2020-2031)
4.2.1 Global Pharmaceuticals and Excipients Revenue by Type (2020-2025)
4.2.2 Global Pharmaceuticals and Excipients Revenue by Type (2026-2031)
4.2.3 Global Pharmaceuticals and Excipients Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceuticals and Excipients Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceuticals and Excipients Sales by Application (2020-2031)
5.1.1 Global Pharmaceuticals and Excipients Sales by Application (2020-2025)
5.1.2 Global Pharmaceuticals and Excipients Sales by Application (2026-2031)
5.1.3 Global Pharmaceuticals and Excipients Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceuticals and Excipients Revenue by Application (2020-2031)
5.2.1 Global Pharmaceuticals and Excipients Revenue by Application (2020-2025)
5.2.2 Global Pharmaceuticals and Excipients Revenue by Application (2026-2031)
5.2.3 Global Pharmaceuticals and Excipients Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceuticals and Excipients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dow
6.1.1 Dow Company Information
6.1.2 Dow Description and Business Overview
6.1.3 Dow Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dow Pharmaceuticals and Excipients Product Portfolio
6.1.5 Dow Recent Developments/Updates
6.2 BASF
6.2.1 BASF Company Information
6.2.2 BASF Description and Business Overview
6.2.3 BASF Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BASF Pharmaceuticals and Excipients Product Portfolio
6.2.5 BASF Recent Developments/Updates
6.3 ER-KANG
6.3.1 ER-KANG Company Information
6.3.2 ER-KANG Description and Business Overview
6.3.3 ER-KANG Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ER-KANG Pharmaceuticals and Excipients Product Portfolio
6.3.5 ER-KANG Recent Developments/Updates
6.4 JRS Pharma
6.4.1 JRS Pharma Company Information
6.4.2 JRS Pharma Description and Business Overview
6.4.3 JRS Pharma Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 JRS Pharma Pharmaceuticals and Excipients Product Portfolio
6.4.5 JRS Pharma Recent Developments/Updates
6.5 Lubrizol
6.5.1 Lubrizol Company Information
6.5.2 Lubrizol Description and Business Overview
6.5.3 Lubrizol Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lubrizol Pharmaceuticals and Excipients Product Portfolio
6.5.5 Lubrizol Recent Developments/Updates
6.6 Ashland
6.6.1 Ashland Company Information
6.6.2 Ashland Description and Business Overview
6.6.3 Ashland Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ashland Pharmaceuticals and Excipients Product Portfolio
6.6.5 Ashland Recent Developments/Updates
6.7 Roquette
6.7.1 Roquette Company Information
6.7.2 Roquette Description and Business Overview
6.7.3 Roquette Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Roquette Pharmaceuticals and Excipients Product Portfolio
6.7.5 Roquette Recent Developments/Updates
6.8 Shin-Etsu
6.8.1 Shin-Etsu Company Information
6.8.2 Shin-Etsu Description and Business Overview
6.8.3 Shin-Etsu Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shin-Etsu Pharmaceuticals and Excipients Product Portfolio
6.8.5 Shin-Etsu Recent Developments/Updates
6.9 Evonik
6.9.1 Evonik Company Information
6.9.2 Evonik Description and Business Overview
6.9.3 Evonik Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Evonik Pharmaceuticals and Excipients Product Portfolio
6.9.5 Evonik Recent Developments/Updates
6.10 ABITEC Corp
6.10.1 ABITEC Corp Company Information
6.10.2 ABITEC Corp Description and Business Overview
6.10.3 ABITEC Corp Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ABITEC Corp Pharmaceuticals and Excipients Product Portfolio
6.10.5 ABITEC Corp Recent Developments/Updates
6.11 Signet Chemical Corporation
6.11.1 Signet Chemical Corporation Company Information
6.11.2 Signet Chemical Corporation Description and Business Overview
6.11.3 Signet Chemical Corporation Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio
6.11.5 Signet Chemical Corporation Recent Developments/Updates
6.12 Sigachi Industries
6.12.1 Sigachi Industries Company Information
6.12.2 Sigachi Industries Description and Business Overview
6.12.3 Sigachi Industries Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sigachi Industries Pharmaceuticals and Excipients Product Portfolio
6.12.5 Sigachi Industries Recent Developments/Updates
6.13 MEGGLE AG
6.13.1 MEGGLE AG Company Information
6.13.2 MEGGLE AG Description and Business Overview
6.13.3 MEGGLE AG Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MEGGLE AG Pharmaceuticals and Excipients Product Portfolio
6.13.5 MEGGLE AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceuticals and Excipients Industry Chain Analysis
7.2 Pharmaceuticals and Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceuticals and Excipients Production Mode & Process Analysis
7.4 Pharmaceuticals and Excipients Sales and Marketing
7.4.1 Pharmaceuticals and Excipients Sales Channels
7.4.2 Pharmaceuticals and Excipients Distributors
7.5 Pharmaceuticals and Excipients Customer Analysis
8 Pharmaceuticals and Excipients Market Dynamics
8.1 Pharmaceuticals and Excipients Industry Trends
8.2 Pharmaceuticals and Excipients Market Drivers
8.3 Pharmaceuticals and Excipients Market Challenges
8.4 Pharmaceuticals and Excipients Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pharmaceuticals and Excipients Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pharmaceuticals and Excipients Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pharmaceuticals and Excipients Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pharmaceuticals and Excipients Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Pharmaceuticals and Excipients Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharmaceuticals and Excipients Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pharmaceuticals and Excipients Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pharmaceuticals and Excipients Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pharmaceuticals and Excipients, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pharmaceuticals and Excipients, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharmaceuticals and Excipients, Product Type & Application
 Table 12. Global Key Manufacturers of Pharmaceuticals and Excipients, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharmaceuticals and Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals and Excipients as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceuticals and Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pharmaceuticals and Excipients Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Pharmaceuticals and Excipients Sales Market Share by Region (2020-2025)
 Table 19. Global Pharmaceuticals and Excipients Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Pharmaceuticals and Excipients Sales Market Share by Region (2026-2031)
 Table 21. Global Pharmaceuticals and Excipients Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2020-2025)
 Table 23. Global Pharmaceuticals and Excipients Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2026-2031)
 Table 25. North America Pharmaceuticals and Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pharmaceuticals and Excipients Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Pharmaceuticals and Excipients Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Pharmaceuticals and Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pharmaceuticals and Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pharmaceuticals and Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pharmaceuticals and Excipients Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Pharmaceuticals and Excipients Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Pharmaceuticals and Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pharmaceuticals and Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pharmaceuticals and Excipients Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pharmaceuticals and Excipients Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Pharmaceuticals and Excipients Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Pharmaceuticals and Excipients Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pharmaceuticals and Excipients Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceuticals and Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pharmaceuticals and Excipients Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Pharmaceuticals and Excipients Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Pharmaceuticals and Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceuticals and Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pharmaceuticals and Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Pharmaceuticals and Excipients Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pharmaceuticals and Excipients Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pharmaceuticals and Excipients Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Pharmaceuticals and Excipients Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Pharmaceuticals and Excipients Sales Market Share by Type (2020-2025)
 Table 53. Global Pharmaceuticals and Excipients Sales Market Share by Type (2026-2031)
 Table 54. Global Pharmaceuticals and Excipients Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pharmaceuticals and Excipients Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2020-2025)
 Table 57. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2026-2031)
 Table 58. Global Pharmaceuticals and Excipients Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Pharmaceuticals and Excipients Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Pharmaceuticals and Excipients Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Pharmaceuticals and Excipients Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Pharmaceuticals and Excipients Sales Market Share by Application (2020-2025)
 Table 63. Global Pharmaceuticals and Excipients Sales Market Share by Application (2026-2031)
 Table 64. Global Pharmaceuticals and Excipients Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pharmaceuticals and Excipients Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2020-2025)
 Table 67. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2026-2031)
 Table 68. Global Pharmaceuticals and Excipients Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Pharmaceuticals and Excipients Price (US$/Ton) by Application (2026-2031)
 Table 70. Dow Company Information
 Table 71. Dow Description and Business Overview
 Table 72. Dow Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Dow Pharmaceuticals and Excipients Product
 Table 74. Dow Recent Developments/Updates
 Table 75. BASF Company Information
 Table 76. BASF Description and Business Overview
 Table 77. BASF Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. BASF Pharmaceuticals and Excipients Product
 Table 79. BASF Recent Developments/Updates
 Table 80. ER-KANG Company Information
 Table 81. ER-KANG Description and Business Overview
 Table 82. ER-KANG Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. ER-KANG Pharmaceuticals and Excipients Product
 Table 84. ER-KANG Recent Developments/Updates
 Table 85. JRS Pharma Company Information
 Table 86. JRS Pharma Description and Business Overview
 Table 87. JRS Pharma Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. JRS Pharma Pharmaceuticals and Excipients Product
 Table 89. JRS Pharma Recent Developments/Updates
 Table 90. Lubrizol Company Information
 Table 91. Lubrizol Description and Business Overview
 Table 92. Lubrizol Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Lubrizol Pharmaceuticals and Excipients Product
 Table 94. Lubrizol Recent Developments/Updates
 Table 95. Ashland Company Information
 Table 96. Ashland Description and Business Overview
 Table 97. Ashland Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Ashland Pharmaceuticals and Excipients Product
 Table 99. Ashland Recent Developments/Updates
 Table 100. Roquette Company Information
 Table 101. Roquette Description and Business Overview
 Table 102. Roquette Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Roquette Pharmaceuticals and Excipients Product
 Table 104. Roquette Recent Developments/Updates
 Table 105. Shin-Etsu Company Information
 Table 106. Shin-Etsu Description and Business Overview
 Table 107. Shin-Etsu Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Shin-Etsu Pharmaceuticals and Excipients Product
 Table 109. Shin-Etsu Recent Developments/Updates
 Table 110. Evonik Company Information
 Table 111. Evonik Description and Business Overview
 Table 112. Evonik Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Evonik Pharmaceuticals and Excipients Product
 Table 114. Evonik Recent Developments/Updates
 Table 115. ABITEC Corp Company Information
 Table 116. ABITEC Corp Description and Business Overview
 Table 117. ABITEC Corp Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. ABITEC Corp Pharmaceuticals and Excipients Product
 Table 119. ABITEC Corp Recent Developments/Updates
 Table 120. Signet Chemical Corporation Company Information
 Table 121. Signet Chemical Corporation Description and Business Overview
 Table 122. Signet Chemical Corporation Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Signet Chemical Corporation Pharmaceuticals and Excipients Product
 Table 124. Signet Chemical Corporation Recent Developments/Updates
 Table 125. Sigachi Industries Company Information
 Table 126. Sigachi Industries Description and Business Overview
 Table 127. Sigachi Industries Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Sigachi Industries Pharmaceuticals and Excipients Product
 Table 129. Sigachi Industries Recent Developments/Updates
 Table 130. MEGGLE AG Company Information
 Table 131. MEGGLE AG Description and Business Overview
 Table 132. MEGGLE AG Pharmaceuticals and Excipients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. MEGGLE AG Pharmaceuticals and Excipients Product
 Table 134. MEGGLE AG Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Pharmaceuticals and Excipients Distributors List
 Table 138. Pharmaceuticals and Excipients Customers List
 Table 139. Pharmaceuticals and Excipients Market Trends
 Table 140. Pharmaceuticals and Excipients Market Drivers
 Table 141. Pharmaceuticals and Excipients Market Challenges
 Table 142. Pharmaceuticals and Excipients Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceuticals and Excipients
 Figure 2. Global Pharmaceuticals and Excipients Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceuticals and Excipients Market Share by Type: 2024 & 2031
 Figure 4. Triglycerides Product Picture
 Figure 5. Mannitol Product Picture
 Figure 6. Sorbitol Product Picture
 Figure 7. Sucrose Product Picture
 Figure 8. Dextrose Product Picture
 Figure 9. Starch Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Pharmaceuticals and Excipients Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Pharmaceuticals and Excipients Market Share by Application: 2024 & 2031
 Figure 13. Oral Formulations
 Figure 14. Topical Formulations
 Figure 15. Parenteral Formulations
 Figure 16. Other
 Figure 17. Global Pharmaceuticals and Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Pharmaceuticals and Excipients Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Pharmaceuticals and Excipients Sales (2020-2031) & (Kiloton)
 Figure 20. Global Pharmaceuticals and Excipients Average Price (US$/Ton) & (2020-2031)
 Figure 21. Pharmaceuticals and Excipients Report Years Considered
 Figure 22. Pharmaceuticals and Excipients Sales Share by Manufacturers in 2024
 Figure 23. Global Pharmaceuticals and Excipients Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Pharmaceuticals and Excipients Players: Market Share by Revenue in Pharmaceuticals and Excipients in 2024
 Figure 25. Pharmaceuticals and Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Pharmaceuticals and Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Pharmaceuticals and Excipients Sales Market Share by Country (2020-2031)
 Figure 28. North America Pharmaceuticals and Excipients Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Pharmaceuticals and Excipients Sales Market Share by Country (2020-2031)
 Figure 32. Europe Pharmaceuticals and Excipients Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Pharmaceuticals and Excipients Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Pharmaceuticals and Excipients Revenue Market Share by Region (2020-2031)
 Figure 40. China Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Pharmaceuticals and Excipients Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Pharmaceuticals and Excipients Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Pharmaceuticals and Excipients Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Pharmaceuticals and Excipients Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Pharmaceuticals and Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Pharmaceuticals and Excipients by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Pharmaceuticals and Excipients by Type (2020-2031)
 Figure 62. Global Pharmaceuticals and Excipients Price (US$/Ton) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Pharmaceuticals and Excipients by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Pharmaceuticals and Excipients by Application (2020-2031)
 Figure 65. Global Pharmaceuticals and Excipients Price (US$/Ton) by Application (2020-2031)
 Figure 66. Pharmaceuticals and Excipients Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart